CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 7,312 shares (grant or award)
- 4 Grant or award Director acquired 9,140 shares (grant or award)
- 4 Grant or award Director acquired 5,027 shares (grant or award)
- 4 Grant or award Director acquired 14,624 shares (grant or award)
- 4 Open-market buy Director bought 910,000 shares at $5.45 ($4,959,318)
- 4 Open-market buy Director bought 150,000 shares at $5.35 ($801,900)
- 4 Open-market buy SVP, Chief Medical Officer bought 3,000 shares at $5.59 ($16,755)
- 4 Open-market buy President and CEO bought 10,000 shares at $5.34 ($53,370)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 7,170 shares at $6.00 ($43,020)
- 8-K Event Shareholder vote results
- 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 7,170 shares at $5.50 ($39,435)
- ARS Other Annual Report to Security Holders
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
Page 46 of 62 · 1,224 filings